Yongzhao Mu

Title: Yongzhao Mu and PRMT5-Inhibitor Innovation.

Introduction

Yongzhao Mu is an inventor based in Shanghai, China, associated with Innovstone Therapeutics Limited. His patent work concerns a compound designed to inhibit PRMT5, an enzyme relevant to certain tumor-related diseases.

Latest Patents

Mu is credited with 1 patent: “Compound Having Anti-Tumor Activity and Use Thereof.” The patent describes a compound represented by formula (I) that acts as a PRMT5 inhibitor. Reported experiments found strong inhibitory effects on PRMT5 enzyme activity and tumor-cell growth, suggesting potential for treating PRMT5-mediated diseases. The patent also describes a synthesis method intended to be straightforward to operate and suitable for large-scale industrial production and application.

Career Highlights

Mu’s listed patent activity connects his work with the development of potential anti-tumor compounds and practical methods for synthesizing them. His company affiliation is Innovstone Therapeutics Limited.

Collaborations

Yunlong Song and Wenqing Xu are identified as Mu’s coworkers. Their names are associated with the collaborative context provided for the patent.

Conclusion

Yongzhao Mu’s patent focuses on a PRMT5-inhibiting compound and a synthesis approach intended to support further development and production, highlighting his contribution to anti-tumor innovation.